))
A Discussion with George Haywood: Biotech Investing, Synaptogenix & Petros
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 16, 2023 23:24 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 337249291 series 3380517
المحتوى المقدم من Encode Ideas, L.P., Encode Ideas, and L.P.. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Encode Ideas, L.P., Encode Ideas, and L.P. أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
An interview with George Haywood, a well-known investor, where we discuss his perspective on biotech investing. During the interview, we cover some of George's previous biotech successes, including AVI Biopharma / Sarepta, Martek & Amarin, and his current favorite biotech names, Synaptogenix & Petros.
Companies discussed during the podcast;
- Synaptogenix, Inc. (Nasdaq: SNPX)
- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI)
- Sarepta Therapeutics, Inc. (Nasdaq: SRPT)
- Cassava Sciences, Inc. (Nasdaq: SAVA)
- Biogen Inc. (Nasdaq: BIIB)
- Pfizer Inc. (NYSE: PFE)
- Amarin Corporation plc (Nasdaq: AMRN)
7 حلقات
مشاركة
